We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
General advice on vigilance - electronic cigarettes devices and refill containers.
Guidance for healthcare professionals on providing free prescriptions for participants in the HEAL-COVID or STIMULATE-ICP long COVID clinical trials.
UKHSA offers a unique opportunity to harness world-class intellectual, scientific, and operational expertise for public health solutions.
MHRA scientific and regulatory advice for COVID-19 vaccine developers
These temporary good manufacturing practice (GMP) flexibilities will be allowed to address the current exceptional circumstances
VDEC provides a number of services for vaccines post-licensure
We can provide access to world-class regulatory knowledge, expertise and experience from within the MHRA.
Submitting notifications on the European common entry gate for Northern Ireland for suppliers of e-cigarettes and e-liquids.
Acceptable naming, presentation and packaging of nicotine-containing electronic cigarettes and refill containers.
How to report adverse incidents involving cardiac ablation devices under the vigilance system.
Submitting annual reports on sales of electronic cigarettes and refill containers.
Guidance on the submission and content of notifications for Northern Ireland
Report showing opportunities and challenges for community pharmacy teams to further support the public’s health.
For manufacturers reporting adverse incidents with neurostimulators under the vigilance system.
This guidance clarifies the expectations on the application of the further pharmacovigilance provisions set out within the updated CIR 520/2012 for UK authorised products.
To celebrate International Women’s Day 2023, some of our colleagues have shared their passion for STEM.
£500k is available to fund the development of novel PoC diagnostics devices.
Guidance for specialists for initiation of valproate in female patients and for annual review and pregnancy testing to support adherence to pregnancy prevention requirements during the pandemic.
Find out about coronavirus (COVID-19) treatments available outside of hospital, including information on free prescriptions and lateral flow tests.
Sets out the payment due from members of the voluntary scheme for branded medicines pricing and access in 2020.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).